NETOsys Website
Built and maintain the public web presence for NETOsys, translating NET biology, diagnostics, and translational research into a clear site for scientific and partner audiences.
View live siteScientist. Builder. Systems thinker.
PhD immunologist and biotech development lead working across translational diagnostics, assay strategy, scientific systems, and practical tools.
I bring research discipline to biotech development, scientific operations, software development, website building, automation, and applied AI.
About
My background is rooted in rigorous scientific inquiry. I earned my B.Sc. Honours, M.Sc., and Ph.D. in Microbiology and Immunology at McGill University. My doctoral work focused on manipulating the innate and adaptive immune responses to develop novel therapeutic approaches for Aspergillus fumigatus pulmonary infections. That work included basic and vaccine-based research into host defense, airway infection, and how immune pathways could be directed toward better protection.
As my career progressed, I moved into translational molecular biology and antibody-based work across both academic and industry settings. I now serve as Chief Development Officer at NETOsys, where I am helping advance NET biology into blood-based diagnostic and translational research tools. Today, I also apply that same analytical discipline to practical software, tools, and systems, while immunology, host-pathogen interactions, and molecular biology remain core parts of my background and interests.
Current Role
Chief Development Officer at NETOsys
Translational Work
NET biology, blood-based diagnostics, assay strategy
Education
Ph.D. Microbiology & Immunology, McGill
Ph.D. Focus
Innate and adaptive immune responses to Aspergillus fumigatus pulmonary infection
Now
These days, my main focus is my role as Chief Development Officer at NETOsys, where I am helping translate NET biology into blood-based diagnostic and translational research tools.
The work brings together immunology, assay development, biotech operations, documentation systems, biomarker validation, and practical scientific tools, while I continue to keep a selective interest in useful software development, website building, automation, and AI-assisted workflows.
Portfolio
Selected things I have built, shipped, or helped shape.
Listmize
Built a product for structured capture and decision workflows, with cleaner inputs, better organization, and practical support for turning rough ideas into usable lists.
View live siteResearch
Timeline
- 2007-2018 McGill University B.Sc. Hons, M.Sc., Ph.D. Student
- 2019 RI-MUHC Postdoctoral Fellow
- 2020-2025 IRIC (Institute for Research in Immunology and Cancer) Postdoctoral Fellow & Research Assistant
- 2020-2025 MediMabs Postdoctoral Fellow
Publications
View on PubMed- The IL-1 Receptor Is Required to Maintain Neutrophil Viability and Function During Aspergillus fumigatus Airway Infection.
- A Murine Model for Chronic A. fumigatus Airway Infections.
- Galectin-3 enhances neutrophil motility and extravasation into the airways during Aspergillus fumigatus infection.
- Contribution of IL-1RI Signaling to Protection against Cryptococcus neoformans 52D in a Mouse Model of Infection.
- Aspergillus fumigatus CalA binds to integrin alpha(5)beta(1) and mediates host cell invasion.
- Posaconazole-Loaded Leukocytes as a Novel Treatment Strategy Targeting Invasive Pulmonary Aspergillosis.
- Deacetylation of Fungal Exopolysaccharide Mediates Adhesion and Biofilm Formation.
- Eyelid Mycetoma Masquerading as Sebaceous Carcinoma.
- The Fungal Exopolysaccharide Galactosaminogalactan Mediates Virulence by Enhancing Resistance to Neutrophil Extracellular Traps.
- Evolution of the Immune Response to Chronic Airway Colonization with Aspergillus fumigatus Hyphae.
- Impact of Leishmania mexicana infection on dendritic cell signaling and functions.
- Host cell signalling and leishmania mechanisms of evasion.
- Identification of key cytosolic kinases containing evolutionarily conserved kinase tyrosine-based inhibitory motifs (KTIMs).
Connect
I tend to be interested in a wide mix of things, from science and immunology to development, automation, systems, and practical ideas worth building. If you think there may be common ground, LinkedIn is the best place to get in touch.
Connect on LinkedIn